Breaking News

Genentech Acquires OriGene TrueClone Collection

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genentech has purchased OriGene Technologies, Inc.’s TrueClone Collection of full-length human cDNAs suitable for transfection and direct in vitro expression. OriGene cDNA clones are expression-ready, authentic full-length cDNA plasmids for use in target and lead identification and validation. The cDNAs allow scientists to easily query the roles of genes in disease phenotypes and pathways. “OriGene’s mission is to build the most comprehensive collection of human full-lengt...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters